Trust Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
ATO
HCM
AAMU
FWCM
Trust Investment Advisors's ABBV Position: Q2 2026 in Review
Trust Investment Advisors increased its AbbVie (ABBV) stake by 0.63% in Q2 2026, buying an estimated $1.51K and bringing the position to 1,118 shares worth $281K. The position accounts for 0.13% of the portfolio, ranked #87.
Trust Investment Advisors first reported a position in ABBV in Q4 2020 and has held it in 17 quarters since. The position peaked at $1.91M in Q4 2022. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Trust Investment Advisors held 1,118 shares of AbbVie worth $281K as of Q2 2026.
- Trust Investment Advisors bought 7 AbbVie shares in Q2 2026, an estimated $1.51K.
- AbbVie made up 0.13% of Trust Investment Advisors's portfolio in Q2 2026, its #87 holding.
- Trust Investment Advisors first reported a position in AbbVie in Q4 2020 and has held it in 17 quarters since.
- Trust Investment Advisors's AbbVie position peaked at $1.91M in Q4 2022.
- 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Trust Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.